260 related articles for article (PubMed ID: 2095718)
21. Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization.
Otani H; Engelman RM; Rousou JA; Breyer RH; Clement R; Prasad R; Klar J; Das DK
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):267-74. PubMed ID: 2915562
[TBL] [Abstract][Full Text] [Related]
22. Effects of nitroglycerin on transmural energy metabolism in the underperfused canine heart.
Higuchi M
J Pharmacol Exp Ther; 1982 Sep; 222(3):694-8. PubMed ID: 6809931
[TBL] [Abstract][Full Text] [Related]
23. Participation of the vasodilating property of nipradilol in improving ischemic derangement of myocardial energy metabolism.
Higuchi M
J Cardiovasc Pharmacol; 1989 Jul; 14(1):157-65. PubMed ID: 2475707
[TBL] [Abstract][Full Text] [Related]
24. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
Eddy LJ; Oei HH; Glenn TM
Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
[TBL] [Abstract][Full Text] [Related]
25. Effects of thoracic epidural anesthesia on myocardial pH and metabolism during ischemia.
Tsuchida H; Omote T; Miyamoto M; Namiki A; Ichihara K; Abiko Y
Acta Anaesthesiol Scand; 1991 Aug; 35(6):508-12. PubMed ID: 1897346
[TBL] [Abstract][Full Text] [Related]
26. Attenuation by isosorbide dinitrate of coronary occlusion-induced acidosis in the dog myocardium.
Abiko Y; Fukushi Y; Haga N; Matsumura H
Br J Pharmacol; 1986 Feb; 87(2):427-32. PubMed ID: 3955308
[TBL] [Abstract][Full Text] [Related]
27. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.
Stanley WC; Hernandez LA; Spires D; Bringas J; Wallace S; McCormack JG
J Mol Cell Cardiol; 1996 May; 28(5):905-14. PubMed ID: 8762030
[TBL] [Abstract][Full Text] [Related]
28. Attenuation by atenolol of myocardial acidosis during ischemia in dogs: contribution of beta-1 adrenoceptors to myocardial acidosis.
Sakai K; Abiko Y
J Pharmacol Exp Ther; 1985 Mar; 232(3):810-6. PubMed ID: 2857788
[TBL] [Abstract][Full Text] [Related]
29. Effects of isoproterenol on the metabolism of normal and ischemic heart.
Andrieu JL; Vial C; Font B; Goldschmidt D; Ollagnier M; Faucon G
Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):255-69. PubMed ID: 7406584
[TBL] [Abstract][Full Text] [Related]
30. Effect of lidocaine on the accumulation of non-esterified fatty acids in the ischemic perfused rat heart.
Nakamura K; Ichihara K; Abiko Y
Eur J Pharmacol; 1989 Oct; 169(2-3):259-67. PubMed ID: 2806383
[TBL] [Abstract][Full Text] [Related]
31. Is ischemia-induced pH decrease of dog myocardium respiratory or metabolic acidosis?
Ichihara K; Haga N; Abiko Y
Am J Physiol; 1984 May; 246(5 Pt 2):H652-7. PubMed ID: 6426324
[TBL] [Abstract][Full Text] [Related]
32. Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs.
Abiko Y; Nishimura T; Sakai K
Br J Pharmacol; 1984 Feb; 81(2):409-11. PubMed ID: 6231074
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of ischaemia-induced regional myocardial acidosis by bevantolol, a beta 1-adrenoceptor antagonist, in dogs.
Hino T; Sakai K; Ichihara K; Abiko Y
Pharmacol Toxicol; 1989 Apr; 64(4):324-8. PubMed ID: 2568629
[TBL] [Abstract][Full Text] [Related]
34. Effects of bunazosin, a selective alpha 1-adrenergic blocking agent, on myocardial energy metabolism in ischemic dog heart.
Yoshida R; Ichihara K; Abiko Y
Jpn J Pharmacol; 1990 Aug; 53(4):435-41. PubMed ID: 1976843
[TBL] [Abstract][Full Text] [Related]
35. [Effects of cibenzoline on myocardial ischemia].
Ohmi H; Hino T; Yamamoto K; Kamigaki M; Nakamura K; Ichihara K; Abiko Y
Nihon Yakurigaku Zasshi; 1988 Nov; 92(5):325-35. PubMed ID: 3243514
[TBL] [Abstract][Full Text] [Related]
36. Effect of nipradilol on myocardial energy metabolism in the dog ischaemic heart.
Hayase N; Chiba K; Ichihara K; Inagaki S; Abiko Y
J Pharm Pharmacol; 1990 Jun; 42(6):419-22. PubMed ID: 1979622
[TBL] [Abstract][Full Text] [Related]
37. Attenuation of ischemia-induced regional myocardial acidosis by LP-805, a newly developed vasodilator, in dogs.
Ichihara K; Morimoto T; Shiba T; Tsujitani M; Abiko Y
Eur J Pharmacol; 1991 Nov; 204(2):127-33. PubMed ID: 1806383
[TBL] [Abstract][Full Text] [Related]
38. Effect of NCO-700, an inhibitor of protease, on myocardial pH decreased by coronary occlusion in dogs.
Haga N; Ishibashi T; Hara A; Abiko Y
Pharmacology; 1985; 31(4):208-17. PubMed ID: 4059326
[TBL] [Abstract][Full Text] [Related]
39. Transmural gradients in ventricular tissue metabolites produced by stopping coronary blood flow in the dog.
Dunn RB; Griggs DM
Circ Res; 1975 Oct; 37(4):438-45. PubMed ID: 1182935
[TBL] [Abstract][Full Text] [Related]
40. Different effects of interventions suppressing free fatty acid metabolism on myocardial ischemia.
Kahles H; Hellige G; Hunnemann DH; Junggeburth J; Kochsiek K
Clin Cardiol; 1984 Jun; 7(6):341-8. PubMed ID: 6430618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
